Eli Lilly's tirzepatide and Boehringer Ingelheim's survodutide grab the spotlight at EASL with new phase 2 data in metabolic dysfunction-associated steatohepatitis (MASH) ...

PathAI's artificial intelligence tool for diagnosing MASH has become the first to be recommended under the EMA's Qualification Opinion framework.

Text-to-image AI art generators are cutting-edge tools that use artificial intelligence (AI) to turn written descriptions into visual art. At the heart of these generators is a complex process where ...